Populations appropriate for diabetes screening with retesting every 3 years
The USPSTF recommends diabetes screening as part of a cardiovascular risk assessment in asymptomatic adults who are overweight or obese and aged between 40 and 70.
©6okean - stock.adobe.com
Patients with pyelonephritis
Aymptomatic people with BMI > 25 kg/m2 (23 kg/m2 if Asian-American)
Age > 45
Children or adolescents with BMI > 85th centile or with additional risk factors
High-risk racial-ethnic background
First-degree relative with T2DM
History of GDM
PCOS
TGs > 250 ml/dL or HDL cholesterol < 35 mg/dL
History of CVD
Inactivity, severe obesity (BMI > 35 kg/m2), acanthosis nigricans
IGT, IFG or prediabetes: restest annualy
BMI = body mass index; CVD = cardiovascular disease; GDM = gestational diabetes; HDL = high-density lipoprotein; IGT = impaired glucose tolerance; IFG = impaired fasting glucose; PCOS = polycystic ovary syndrome; TG = triglycerides; T2DM = type 2 diabetes mellitus
The US Preventive Services Task Force recommends diabetes screening as part of a cardiovascular risk assessment in asymptomatic adults who are overweight or obese and aged between 40 and 70. Individuals with a history of PCOS< GDM, and those of higher-risk racial and ethnic groups should be considered for screening at younger ages and lower body mass indexes.
Read more: Type 2 diabetes in the non-pregnant patient
Major congenital malformations not linked to first trimester tetracycline use
November 20th 2024A large population-based study found that first-trimester tetracycline exposure does not elevate the risk of major congenital malformations, though specific risks for nervous system and eye anomalies warrant further research.
Read More
IUD placement within 48 hours nonsuperior vs 2 to 4 weeks after abortion
November 19th 2024A study reveals no significant difference in 6-month intrauterine device use between placements within 48 hours or 2 to 4 weeks after a second-trimester abortion, though earlier placement carries a higher expulsion risk.
Read More
